Pathstone Holdings
MRK icon

Pathstone Holdings’s Merck MRK Stock Holding History

Pathstone Holdings’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.1M Buy
599,421
+118,786
+25% +$13.9M 0.22% 71
2026
Q1 		$57.8M Buy
480,635
+11,055
+2% +$1.28M 0.23% 66
2025
Q4 		$49.5M Buy
469,580
+3,988
+0.9% +$374K 0.19% 76
2025
Q3 		$39.1M Buy
465,592
+2,966
+0.6% +$244K 0.15% 91
2025
Q2 		$36.6M Sell
462,626
-26,709
-5% -$2.12M 0.14% 95
2025
Q1 		$43.9M Sell
489,335
-30,924
-6% -$2.89M 0.19% 84
2024
Q4 		$51.8M Sell
520,259
-8,066
-2% -$832K 0.23% 70
2024
Q3 		$60M Sell
528,325
-7,059
-1% -$839K 0.27% 67
2024
Q2 		$66.3M Sell
535,384
-7,345
-1% -$946K 0.3% 56
2024
Q1 		$71.6M Buy
542,729
+17,990
+3% +$2.22M 0.33% 49
2023
Q4 		$57.4M Buy
+524,739
New +$54.5M 0.31% 56

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pathstone Holdings's MRK Position: Q2 2026 in Review

Pathstone Holdings increased its Merck (MRK) stake by 25% in Q2 2026, buying an estimated $13.9M and bringing the position to 599,421 shares worth $77.1M. The position accounts for 0.22% of the portfolio, ranked #71.

Pathstone Holdings first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pathstone Holdings held 599,421 shares of Merck worth $77.1M as of Q2 2026.
  • Pathstone Holdings bought 118,786 Merck shares in Q2 2026, an estimated $13.9M.
  • Merck made up 0.22% of Pathstone Holdings's portfolio in Q2 2026, its #71 holding.
  • Pathstone Holdings first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.